Key result
Severe prolonged QRS duration (≥150 ms) was associated with a significantly higher risk of 30-day in-hospital mortality (HR 1.909) compared to narrow QRS duration in patients with acute heart failure and cardiogenic shock.
Why the study?
Prolonged QRS duration is linked to poor outcomes in chronic heart failure, but its prognostic value in cardiogenic shock complicating acute heart failure remains unknown.
Does prolonged QRS duration predict 30-day in-hospital mortality in acute heart failure patients with cardiogenic shock?
Cohort (n=211)
Yes
Does prolonged QRS duration predict 30-day in-hospital mortality in acute heart failure patients with cardiogenic shock?
Hazard Ratio: 1.909 (95% CI 1.024–3.558)
Absolute Event Rate: 43.7% vs 24.9%
p-value: p=0.042
Severe prolonged QRS duration (≥150 ms) is an independent predictor of 30-day in-hospital mortality in patients with acute heart failure complicated by cardiogenic shock, serving as a useful marker for early risk stratification.
May aid risk stratification in acute HF shock; leaves open need for prospective validation before guiding care.
Background and Objectives: Prolonged QRS duration is associated with poor outcomes in patients with chronic heart failure (HF). However, the prognostic value of QRS duration in patients with cardiogenic shock complicating acute HF remains unknown. We evaluated the hypothesis that prolonged QRS duration may be associated with short-term mortality among acute HF patients with cardiogenic shock (CS). Methods: From March 2011 through December 2013, a total of 5,625 acute HF patients were consecutively enrolled in ten tertiary university hospitals. Among them, we analyzed patients who presented with CS. Patients were divided into three groups by QRS duration cutoff values of 130 and 150 ms. The primary endpoint was 30-day in-hospital mortality. Results: Two hundred eleven patients presented with CS at admission and those with available electrocardiograms were included in this analysis. There were 35 patients with QRS durations of 150 ms or above, 30 patients with QRS durations between 130 ms and 150 ms, and 146 patients with QRS durations below 130 ms. The 30-day all cause in-hospital mortality rates were 43.7%, 33.1%, and 24.9%, respectively. After multivariate adjustment, severe prolonged QRS duration was a significant prognostic factor for 30-day in-hospital mortality (hazard ratio, 1.909; 95% confidence interval, 1.024-3.558; p=0.042). Conclusions: Prolonged QRS duration was associated with a higher risk of 30-day in-hospital mortality among patients with acute HF who presented with CS. Trial Registration: ClinicalTrials.gov Identifier: NCT01389843.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2020) conducted a cohort in Cardiogenic shock complicating acute heart failure (n=211). Severe prolonged QRS duration (≥150 ms) vs. Narrow QRS duration (<130 ms) was evaluated on 30-day in-hospital mortality (HR 1.909, 95% CI 1.024-3.558, p=0.042). Severe prolonged QRS duration (≥150 ms) was associated with a significantly higher risk of 30-day in-hospital mortality (HR 1.909) compared to narrow QRS duration in patients with acute heart failure and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: